MR‐Linac guided adaptive stereotactic ablative body radiotherapy for recurrent cardiac sarcoma with mitral valve bioprosthesis – a case report
Journal of Medical Radiation Sciences · 2023-06 · 70 (2) · 199-205
DOI: 10.1002/jmrs.669 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Medical Radiation Sciences, online erschienen am 08.03.2023. Verfasst von Vikneswary Batumalai und 8 weiteren Autor:innen. Beteiligte Einrichtung: GenesisCare, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Bioprosthesis, Radiosurgery, Sarcoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We present the first case in the literature of a 78‐year‐old woman with recurrent cardiac sarcoma adjacent to a bioprosthetic mitral valve treated with magnetic resonance linear accelerator (MR‐Linac) guided adaptive stereotactic ablative body radiotherapy (SABR). The patient was treated using a 1.5 T Unity MR‐Linac system (Elekta AB, Stockholm, Sweden). The mean gross tumour volume (GTV) size was 17.9 cm 3 (range 16.6–18.9 cm 3 ) based on daily contours and the mean dose received by the GTV was 41.4 Gy (range 40.9–41.6 Gy) in five fractions. All fractions were completed as planned and the patient tolerated the treatment well with no acute toxicity reported. Follow‐up appointments at 2 and 5 months after the last treatment showed stable disease and good symptomatic relief. Results of transthoracic echocardiogram after radiotherapy showed that the mitral valve prosthesis was normally seated with regular functionality. This study provides evidence that MR‐Linac guided adaptive SABR is a safe and viable option for the treatment of recurrent cardiac sarcoma with mitral valve bioprosthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- GenesisCare, Sydney, New South Wales, Australia.
- School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia.
- Centre for Medical and Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
- Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Vikneswary Batumalai
Zitieren
APA
Batumalai, V., Carr, M., Jameson, M., Crawford, D., Jelen, U., Pagulayan, C., Twentyman, T., Hong, A., & de Leon, J. (2023). MR‐Linac guided adaptive stereotactic ablative body radiotherapy for recurrent cardiac sarcoma with mitral valve bioprosthesis – a case report. Journal of Medical Radiation Sciences, 70(2), 199-205. https://doi.org/10.1002/jmrs.669
Vancouver
Batumalai V, Carr M, Jameson M, Crawford D, Jelen U, Pagulayan C, et al. MR‐Linac guided adaptive stereotactic ablative body radiotherapy for recurrent cardiac sarcoma with mitral valve bioprosthesis – a case report. Journal of Medical Radiation Sciences. 2023;70(2):199-205. doi:10.1002/jmrs.669
BibTeX
@article{Batumalai2023,
author = {Batumalai, Vikneswary and Carr, Madeline and Jameson, Michael and Crawford, David and Jelen, Urszula and Pagulayan, Claire and Twentyman, Tania and Hong, Angela and de Leon, Jeremy},
title = {MR‐Linac guided adaptive stereotactic ablative body radiotherapy for recurrent cardiac sarcoma with mitral valve bioprosthesis – a case report},
journal = {Journal of Medical Radiation Sciences},
year = {2023},
volume = {70},
number = {2},
pages = {199--205},
doi = {10.1002/jmrs.669}
}
EUVIMED